• Check out these discounted items on TikTok

NEW ARTICLE: IVERMECTIN, FENBENDAZOLE and MEBENDAZOLE Testimonial – 80 year old retired nurse with Stage 4 Triple Negative Breast Cancer with lung metastases and axillary nodes gets to "Cancer Free" after 1 year.

Some patients are petrified of Ivermectin or Fenbendazole. Not

Ivermectin, Fenbendazole, and Mebendazole: A Remarkable Cancer Journey

In a groundbreaking testimonial shared by Dr. William Makis, an 80-year-old retired nurse has achieved an astonishing milestone in her battle against Stage 4 Triple Negative Breast Cancer. After one year of treatment involving Ivermectin, Fenbendazole, and Mebendazole, she has reportedly become "cancer-free." This incredible story highlights the potential of these medications, which have traditionally been used for treating parasitic infections, to aid in cancer treatment.

Understanding Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) is one of the most aggressive forms of breast cancer, characterized by the absence of three key receptors: estrogen, progesterone, and the human epidermal growth factor receptor 2 (HER2). This makes it challenging to treat, as many standard therapies target these receptors. The prognosis for TNBC can be grim, particularly when metastases occur in the lungs and lymph nodes, as seen in this case.

The Role of Ivermectin, Fenbendazole, and Mebendazole in Cancer Treatment

Ivermectin, Fenbendazole, and Mebendazole are anthelmintic medications that have gained attention for their potential anti-cancer properties.

• Ivermectin is primarily known for its effectiveness against parasitic infections but has shown promise in inhibiting cancer cell growth in laboratory studies.
• Fenbendazole is another anthelmintic agent that has been highlighted for its purported ability to interfere with cancer cell metabolism and promote apoptosis (programmed cell death) in tumor cells.
• Mebendazole, similar to Fenbendazole, has been studied for its potential anti-cancer effects, particularly in disrupting the microtubule structure in cancer cells, thereby inhibiting their division.

  The combined use of these medications may offer a novel approach to treating advanced cancers, particularly when conventional therapies fall short.

  Overcoming Fear and Stigma
  

  Despite the promising results, many patients remain apprehensive about using Ivermectin and Fenbendazole for cancer treatment. Misinformation and a lack of understanding about the potential benefits often lead to fear. However, testimonials like that of the retired nurse serve to illuminate the possibilities that exist outside traditional treatment paradigms. With more patients sharing their success stories, there is hope that these medications will gain wider acceptance as adjunct therapies in oncology.

  Conclusion
  

  The journey of this 80-year-old nurse underscores the need for continued research into alternative cancer treatments, especially for aggressive forms like Triple Negative Breast Cancer. As the medical community explores the potential of Ivermectin, Fenbendazole, and Mebendazole, patients and their families may find inspiration and hope from her story.

  In summary, while further studies and clinical trials are necessary to substantiate the efficacy of these medications in cancer treatment, this remarkable case exemplifies the courage of patients and the innovative spirit of medicine. For those battling cancer, it is essential to stay informed and consider all potential treatment options, including emerging therapies that show promise in the fight against this devastating disease.

NEW ARTICLE: IVERMECTIN, FENBENDAZOLE and MEBENDAZOLE Testimonial – 80 year old retired nurse with Stage 4 Triple Negative Breast Cancer with lung metastases and axillary nodes gets to “Cancer Free” after 1 year.

Some patients are petrified of Ivermectin or Fenbendazole. Not… pic.twitter.com/ZTLcEFYc0E

— William Makis MD (@MakisMD) March 30, 2025

NEW ARTICLE: IVERMECTIN, FENBENDAZOLE and MEBENDAZOLE Testimonial

It’s always incredible to hear stories of hope and triumph, especially when it comes to cancer. Recently, a remarkable testimonial surfaced about an 80-year-old retired nurse who battled Stage 4 Triple Negative Breast Cancer. This brave woman faced lung metastases and involvement of her axillary nodes but managed to achieve a “Cancer Free” status after just one year of treatment. What’s fascinating here is the unconventional approach she took, using Ivermectin, Fenbendazole, and Mebendazole.

Understanding the Treatments: Ivermectin, Fenbendazole, and Mebendazole

If you’re not familiar with these medications, let’s break them down a bit. Ivermectin is primarily known as an anti-parasitic medication, often used to treat infections caused by parasites like roundworms and certain skin conditions. Fenbendazole and Mebendazole are both anthelmintics, typically used to treat parasitic worm infestations in various animals and, in some cases, humans. Their use in cancer therapy, however, is not mainstream and has raised eyebrows in the medical community.

Many patients are understandably wary of these drugs, fearing potential side effects or questioning their efficacy. However, this testimonial showcases how unconventional approaches can sometimes lead to life-altering results. You can read more on the subject from Dr. William Makis, who has been vocal about alternative treatments for cancer.

How Did This Retired Nurse Achieve “Cancer Free” Status?

The journey of this courageous nurse is not just a story of perseverance; it’s a testament to the power of hope and alternative medicine. After receiving her diagnosis, she explored various treatment options, ultimately deciding to incorporate Ivermectin, Fenbendazole, and Mebendazole into her regimen. Through diligent research and consultation with professionals, she learned about their potential benefits in combating cancer cells.

Over the course of a year, she underwent regular monitoring and continued to take these medications alongside other supportive therapies. The results were astounding. Not only did her tumor markers significantly decline, but imaging studies confirmed the absence of cancerous lesions in her lungs and lymph nodes. This change sparked a renewed interest in these medications within the alternative medicine community.

Challenges and Skepticism Surrounding Alternative Treatments

While the nurse’s story is inspiring, it’s crucial to acknowledge the skepticism surrounding the use of Ivermectin, Fenbendazole, and Mebendazole in treating cancer. Many oncologists and healthcare professionals are hesitant to endorse these treatments, primarily due to a lack of extensive clinical trials and regulatory approval for cancer therapy.

Patients often find themselves in a dilemma: should they trust traditional treatments or explore alternative options? The retired nurse’s experience certainly offers an intriguing perspective, but it’s essential for anyone considering these options to engage in thorough discussions with their healthcare providers. Resources like the [American Cancer Society](https://www.cancer.org/) can provide valuable insights into the landscape of cancer treatment.

The Emotional Toll of a Cancer Diagnosis

Being diagnosed with cancer at any age is a heavy burden, but for an 80-year-old, it can feel overwhelmingly daunting. This retired nurse not only had to confront her mortality but also navigate the complex world of treatment options. Through her journey, she found strength in community support and the guidance of healthcare professionals who believed in her choice. It’s a reminder of the importance of mental health and emotional support during such challenging times.

Hope for Others Facing Similar Battles

The story of this nurse is a beacon of hope for many. Patients grappling with Stage 4 Triple Negative Breast Cancer or any aggressive form of cancer often feel hopeless, but this testimonial illustrates that alternative paths can lead to unexpected outcomes. While it’s vital to approach such treatments with caution, staying informed and open-minded can make all the difference.

As more patients explore these options, it’s imperative to document and share their experiences. Platforms dedicated to cancer research and patient testimonials can help illuminate the potential benefits and risks associated with unconventional treatments. You can find more information and supportive communities on websites like [CancerCare](https://www.cancercare.org/).

Final Thoughts: The Future of Cancer Treatment

The medical landscape is ever-evolving, and as we continue to learn more about cancer and its treatment, stories like that of this retired nurse encourage a broader exploration of options. Ivermectin, Fenbendazole, and Mebendazole may not be the first treatments that come to mind for cancer, but they have opened a dialogue about the need for comprehensive approaches to health and wellness.

Whether you’re a patient, a caregiver, or just someone interested in the latest in cancer treatments, it’s crucial to stay informed and advocate for your health. Remember, every journey is unique, and the right path is one that resonates with your beliefs, values, and medical advice.

For those interested in reading the original testimonial, check out [Dr. William Makis’s article](https://twitter.com/MakisMD/status/1906277950045012014) for more details and insights on this compelling case.